IngentaConnect Recent Developments with Prophylactic Human Papillomavirus Vaccin...

Authors: Lewis, Merle; Cutts, Felicity

Source: Recent Advances in Immunization, 2nd Edition, Recent Advances in Immunization, 2nd Edition , pp. 127-139(13)

Publisher: Pan American Health Organization (PAHO)

Abstract:

One of the most important findings in cancer biology in the last quarter of the 20th century is evidence that infection of the lower genital tract with specific "high-risk" types of human papillomaviruses (HPV) causes virtually all cases of cervical carcinoma in women. Evidence also links these infections etiologically with a smaller, less defined fraction of vulvar, vaginal, anal, and penile cancers.

Prophylactic HPV vaccines have shown unprecedented levels of protection against new and persistent HPV infection and, in preliminary results to date, against related high-grade cervical lesions. Thus, these vaccines hold great promise for preventing cervical cancer. Despite the tremendous progress achieved to date in the development of HPV vaccines to prevent cervical cancer, several outstanding issues remain.

This is an article from the book Recent Advances in Immunization, 2^nd edition, which covers combination vaccines, vaccine safety, influenza control, adolescent and adult immunization, human papillomavirus vaccines, and approaches to introducing new vaccines.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$18.60 plus tax Refund Policy

Recent Developments with Prophylactic Human Papillomavirus Vaccines